Redpin Therapeutics

About:

Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.

Website: https://www.redpinrx.com/

Top Investors: Alexandria Venture Investments, New York Ventures, Takeda Ventures, Arkin Bio Ventures, 4BIO Capital

Description:

Redpin Therapeutics operates as a preclinical stage gene therapy company. It develops a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Its approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. The company was founded in 2017 and is headquartered in New York.